Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics

April 17, 2020 to April 19, 2020
DUE TO COVID-19, OUR CONFERENCE IS MOVING ONLINE! JOIN US FROM ANYWHERE IN THE WORLD!
 
Join us for the 9th Annual International Clinical Cancer Genetics and Genomics Conference in conjunction with the Personalized Cancer Care Consortium!

This activity will provide an interdisciplinary educational forum in which to update state-of-the-art science including novel therapies for inherited cancers, discuss real-world cases, curate interesting pedigrees, and prepare case summaries to disseminate new knowledge in translational genomics and evidence-based clinical management of high-risk patients and their family members.
 
Click on the "Get Started!" tab to find out more!
 

   This activity is brought to you in partnership with City of Hope.

 

Click here to tour the virtual conference room!
CONFERENCE PREVIEW

Target Audience

This activity is designed for physicians, physician assistants, advanced nurse practitioners, genetic counselors, oncology nurses, and other healthcare professionals currently providing oncology care and cancer genetics risk assessment services or initiating such care and services in their healthcare system. Special efforts will be made to educate clinicians practicing in geographically or socioeconomically underserved communities.

Learning Objectives

At the conclusion of this activity, participants will be able to:

  • Recall advanced concepts in genetics, genomics, and next generation sequencing (NGS) technologies;
  • Analyze controversies in cancer risk assessment and genetic testing including the integration of polygenic risk scores;
  • Recognize how scientific advances in Lynch syndrome and other inherited solid tumors and hematologic malignancies can improve the clinical management of patients;
  • Discuss how the integration of novel cancer therapies based on genomic alterations in tumor tissue may reveal germline mutations that can guide patient management;
  • Recognize the limitations of genomic testing as it relates to both cancer risk as well as therapeutic selection, including variants of uncertain significance and in silico predictions;
  • Identify how a globally-informed perspective on experimental therapeutics for rare cancers including immunotherapy can improve patient outcomes;
  • Discuss how emerging concepts in cancer interception and cancer risk modifiers including lifestyle and chemoprevention can impact disease management strategies;
  • State the ethical, legal, and social implications of genomic testing in diverse populations.
Additional information
ABMS Core Competencies: 
Patient Care and Procedural Skills
Medical Knowledge
Practice-based Learning and Improvement
Interpersonal and Communication Skills
Systems-based Practice
For more information, please contact:
CME Coordinator Contact Name: 
Meeting Achievements
CME Coordinator Contact Email: 
CME Coordinator Contact Phone: 
(219) 465-1115
AttachmentSize
Conference Brochure2.7 MB
Summary
Available credit: 
  • 17.50 AMA PRA Category 1 Credit™
  • 16.35 Genetic Counseling CEU
  • 17.50 Participation
Event starts: 
04/17/2020 - 7:30am
Event ends: 
04/19/2020 - 11:30am
Activity opens: 
12/04/2019
Activity expires: 
07/18/2020

Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics Schedule
Genetics in Clinical Cancer Care: From Family Reunions to the Frontline of Developmental Therapeutics Schedule

Agenda subject to change.

Webconference
Chicago, IL
United States
THIS ACTIVITY WILL NOW BE OFFERED VIA WEBCONFERENCE!
In light of recommended procedures from leading health officials and organizations in the prevention of COVID-19, course leadership have considered the safety of learners and faculty alike. In order to ensure everyone's safety but still provide these important updates, course leadership have opted to continue the activity via webconference!
 
Questions?
Please contact Meeting Achievements via e-mail here.
 

ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact Meeting Achievements via email at Support@MeetingAchievments.com.

The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.

CONFERENCE LEADERSHIP
Olufunmilayo I. Olopade, MD, FACP  Olufunmilayo Falusi Olopade, MBBS, FACP
  Walter L. Palmer Distinguished Service Professor
  Director, Center for Clinical Cancer Genetics
  Departments of Medicine and Human Genetics
  University of Chicago
 
Walter M. Stadler, MD  Walter M. Stadler, MD
  Fred C. Buffett Professor of Medicine and Surgery
  Dean for Clinical Research
  Director, Genitourinary Oncology Program
  Deputy Director, Comprehensive Cancer Center
  University of Chicago
 
Kathleen Blazer, EdD, MS, LCGC  Kathleen Blazer, EdD, MS, LCGC
  Clinical Assistant Professor
  Associate Director, Cancer Genomics Education Program
  Co-Director, Intensive Course in Cancer Risk Assessment
  Co-Investigator, Cancer Genomics Career Development Program
  City of Hope National Medical Center
 
Olatoyosi Odenike, MD  Olatoyosi Odenike, MD
   Associate Professor of Medicine
  University of Chicago
 
 

Iris Romero, MD, MS  Iris Romero, MD
  Associate Professor of Obstetrics & Gynecology
  Associate Director, Center for Clinical Cancer Genetics
  University of Chicago
 
 
Jeffrey Weitzel, MD  Jeffrey N. Weitzel, MD
  Dr. Norman & Melinda Payson Professor in Medical Oncology
  Director, Division of Clinical Cancer Genomics, Department of Population Sciences
  Director, Cancer Screening & Prevention Programs Network
  Director, Cancer Genomics Education Program
  City of Hope National Medical Center
 
 


Disclosure Declarations
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.

Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.

Physician Credit
The University of Chicago Pritzker School of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians.

The University of Chicago Pritzker School of Medicine designates this live activity for a maximum of 17.5 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
 
Genetic Counselor Credit
The National Society of Genetic Counselors (NSGC) has authorized University of Chicago Pritzker School of Medicine to offer up to 1.635 CEUs or 16.35 Category 1 contact hours for the activity 9th Annual Clinical Cancer Genetics and Genomics Conference. The American Board of Genetic Counseling (ABGC) will accept CEUs earned at this program for the purposes of genetic counselor certification and recertification.
 
American Board of Internal Medicine MOC Part II Credit
Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 17.5 MOC points in the American Board of Internal Medicine's (ABIM) Maintenance of Certification (MOC) program. It is the CME activity provider's responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

Other Healthcare Professional Credit
Other healthcare professionals will receive a Certificate of Participation. For information on the applicability and acceptance of Certificates of Participation for educational activities certified for AMA PRA Category 1 Credit™ from organizations accredited by the ACCME, please consult your professional licensing board. 
 

Please Note: The credit claiming process will close three months after the conference end date. Requests to claim credit after three months will be subject to additional fees.

REGISTRATION
DUE TO COVID-19, OUR CONFERENCE IS MOVING ONLINE! JOIN US FROM ANYWHERE IN THE WORLD!

Please log in or create an account to register. Once logged in, select the profession type that best suits you and click "Register Now!".
 
 
Profession Type
Registration Fee
Physician
$545
Genetic Counselor (Does not include CEU credit)
$350
Genetic Counselor + $25 CEU Fee
$375
Other Healthcare Professionals
$350
Resident/Fellow
$245
Industry$600
 
CANCELLATION POLICY If you cancel your participation in this conference, your registration fee less a $100 administrative fee will be refunded when written notification is received by March 15, 2020. No refunds will be made after March 15, 2020.
 
CCGCoP Members: Enter the code "HOPE20" for $50 off registration.


ALREADY REGISTERED?
Click here to enter the virtual conference room!
 

 
CLAIMING CREDIT
At the end of the course, the credit claiming process will unlock. Return to this page and simply click on "Complete Activity" to proceed.
Please Note: Requests to claim MOC Part II credit must be made within one month to report to ABIM. Requests to claim AMA PRA Category 1 CreditTM credit after three months will be subject to additional fees. The NSGC requires that all CEUs are reported to them within 60 days of the activity.
 
Please login or create an account to proceed.